Decision to fund methylnaltrexone in palliative care

8 December 2017 - PHARMAC is pleased to announce the approval of an agreement with Link Pharmaceuticals Limited for the ...

Read more →

Decision to fund zoster vaccine

9 November 2017 - PHARMAC is pleased to announce the approval of an agreement with Merck Sharpe & Dohme to ...

Read more →

Decision to fund dexamethasone implants (Ozurdex)

13 October 2016 - PHARMAC is pleased to announce the approval of an agreement with Allergan for the listing of ...

Read more →

Agreements for the supply of orthopaedic implants and associated products

6 October 2017 - PHARMAC is pleased to announce the approval of agreements with Medtronic New Zealand Limited (“Medtronic”) and ...

Read more →

Bendamustine funding approved

15 June 2017 - PHARMAC is pleased to announce the approval of an agreement with Janssen-Cilag for the listing of ...

Read more →

Changes to the National Immunisation Schedule - meningococcal C conjugate vaccine

12 June 2017 - PHARMAC is pleased to announce a decision related to the National Immunisation Schedule (NIS) that will ...

Read more →

Proposal for various medicines in the neurology, immunology and nephrology therapeutic areas approved

12 June 2017 - PHARMAC is pleased to announce the approval of a proposal relating to certain medicines in the ...

Read more →

Decision to list 5-aminolevulinic acid hydrochloride (Gliolan) on the Hospital Medicines List

28 April 2017 - PHARMAC is pleased to announce that the approval of an agreement with Specialised Therapeutics Limited for ...

Read more →

New melanoma drug gets Medsafe registration for lung cancer

21 April 2017 - A new drug which was recently funded for melanoma treatment is now registered for lung cancer ...

Read more →

PHARMAC reject request to fund women's hygiene products

19 April 2017 - The government's drug-buying agency has rejected a request to fund women's hygiene products. ...

Read more →

More options for pregnant women and 65+ to get funded influenza vaccines

15 March 2017 - Funded influenza vaccinations will be available from more community pharmacies this year. ...

Read more →

Outcomes from the November 2016 PTAC meeting

13 February 2017 - PHARMAC has published the minutes from the 3-4 November meeting. ...

Read more →

Decision to maintain full subsidy for gefitinib (Iressa) from 1 April 2017

10 February 2017 - PHARMAC is pleased to announce the approval of a proposal to maintain full subsidy for gefitinib ...

Read more →

Decision relating to nicotine replacement therapy RFP

8 February 2017 - PHARMAC has decided to not accept any proposal in response to, and to terminate the process ...

Read more →

Approval of proposal for clostridium botulinum type A toxin (Botox) in DHB hospitals

26 January 2017 - PHARMAC is pleased to announce the approval of an agreement with Allergan to amend the contractual ...

Read more →